Concord Wealth Partners’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.65K | Hold |
200
| – | – | ﹤0.01% | 599 |
|
|
2025
Q1 | $5.86K | Hold |
200
| – | – | ﹤0.01% | 565 |
|
|
2024
Q4 | $6.57K | Hold |
200
| – | – | ﹤0.01% | 570 |
|
|
2024
Q3 | $8.89K | Hold |
200
| – | – | ﹤0.01% | 566 |
|
|
2024
Q2 | $8.62K | Hold |
200
| – | – | ﹤0.01% | 522 |
|
|
2024
Q1 | $5.85K | Hold |
200
| – | – | ﹤0.01% | 636 |
|
|
2023
Q4 | $4.45K | Hold |
200
| – | – | ﹤0.01% | 648 |
|
|
2023
Q3 | $4.95K | Hold |
200
| – | – | ﹤0.01% | 719 |
|
|
2023
Q2 | $5.66K | Hold |
200
| – | – | ﹤0.01% | 684 |
|
|
2023
Q1 | $4.59K | Hold |
200
| – | – | ﹤0.01% | 685 |
|
|
2022
Q4 | $5.62K | Buy |
+200
| New | +$5.62K | ﹤0.01% | 735 |
|
|
2022
Q3 | – | Sell |
-200
| Closed | -$4K | – | 176 |
|
|
2022
Q2 | $4K | Hold |
200
| – | – | ﹤0.01% | 844 |
|
|
2022
Q1 | $6K | Hold |
200
| – | – | ﹤0.01% | 858 |
|
|
2021
Q4 | $7K | Buy |
+200
| New | +$7K | ﹤0.01% | 854 |
|